美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=TENOFOVIR DISOPROXIL FUMARATE"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
TENOFOVIR DISOPROXIL FUMARATE 079071 001 ANDA TENOFOVIR DISOPROXIL FUMARATE TABLET; ORAL 300MG No 2007/11/30 (TA) MATRIX LABS None (Tentative Approval)
EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE 090049 001 ANDA EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET; ORAL 200MG; 300MG No 2009/03/30 (TA) MATRIX LABS LTD None (Tentative Approval)
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE 090437 001 ANDA EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET; ORAL 600MG; 200MG; 300MG No 2009/08/12 (TA) MATRIX LABS LTD None (Tentative Approval)
LAMIVUDINE/TENOFOVIR DISOPROXIL FUMARATE FDC TABS 022459 001 NDA LAMIVUDINE; TENOFOVIR TABLET; ORAL 300MG/300MG No 2009/11/05 (TA) HETERO DRUGS LTD None (Tentative Approval)
LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE 200623 001 NDA LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE TABLET; ORAL 300MG; 300MG No 2011/03/04 (TA) CIPLA LIMITED None (Tentative Approval)
LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE 202171 001 NDA LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE TABLET; ORAL 300MG; 300MG; 200MG No 2011/09/08 (TA) MATRIX LABS LTD None (Tentative Approval)
EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE 201806 001 ANDA EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET; ORAL 200MG; 300MG No 2011/12/22 (TA) HETERO LABS UNIT III None (Tentative Approval)
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE 091593 001 ANDA EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET; ORAL 600MG No 2012/02/27 (TA) CIPLA LIMITED None (Tentative Approval)
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE 091593 002 ANDA EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET; ORAL 200MG No 2012/02/27 (TA) CIPLA LIMITED None (Tentative Approval)
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE 091593 003 ANDA EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET; ORAL 300MG No 2012/02/27 (TA) CIPLA LIMITED None (Tentative Approval)
LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE 203283 001 NDA LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE TABLET; ORAL 300MG; 300MG No 2012/11/08 (TA) MACLEODS PHARMS LTD None (Tentative Approval)
LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE 202529 001 NDA LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE TABLET; ORAL 300MG; 300MG No 2013/05/17 (TA) RANBAXY LABS LTD None (Tentative Approval)
EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE 091055 001 ANDA EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET; ORAL 200MG; 300MG No 2013/07/31 (TA) STRIDES ARCOLAB LTD None (Tentative Approval)
LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE 204505 001 NDA LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE TABLET; ORAL 300MG; 300MG; 200MG No 2013/10/18 (TA) AUROBINDO PHARMA LTD None (Tentative Approval)
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE 203053 001 ANDA EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET; ORAL 600MG; 200MG; 300MG No 2013/10/31 (TA) HETERO LABS LTD V None (Tentative Approval)
EFAVIRENZ, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE 204568 001 NDA EFAVIRENZ;LAMIVUDINE;TENOFOVIR DISOPROXIL FUMARATE TABLET; ORAL 600MG No 2013/12/30 (TA) CIPLA None (Tentative Approval)
EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE 090958 001 ANDA EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET; ORAL 200MG; 300MG No 2014/02/26 (TA) CIPLA LTD None (Tentative Approval)
LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE 205355 001 NDA LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE TABLET; ORAL 300MG; 300MG; 200MG No 2014/03/14 (TA) HETERO LABS LTD III None (Tentative Approval)
EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE 205861 001 NDA EFAVIRENZ;LAMIVUDINE;TENOFOVIR DISOPROXIL FUMARATE TABLET;ORAL 600MG;300MG;300MG No 2014/08/14 (TA) MACLEODS PHARMS LTD None (Tentative Approval)
EMTRICITABINE;TENOFOVIR DISOPROXIL FUMARATE;NEVIRAPINE 206042 001 NDA EMTRICITABINE;TENOFOVIR DISOPROXIL FUMARATE;NEVIRAPINE TABLET;ORAL 200MG;300MG;200MG No 2014/09/12 (TA) MYLAN LABS LTD None (Tentative Approval)
药品名称,活性成分,申请号搜索 高级检索
©2006-2019 DrugFuture->U.S. FDA Drugs Database